Abstract
The role of H. pylori infection in increasing the risk of ischemic heart diseases (IHD) is still debated. We determined serologically the prevalence of overall H. pylori and CagA-positive H. pylori infection in 63 consecutive patients with IHD and 189 gender- and age-matched controls. We also determined in patients the influence of the infection and the CagA serological status on the results of an exercise ECG test and other parameters considered possible variables that may enhance the risk of IHD. The prevalence of H. pylori infection in patients and controls was 79.3% and 73.0%, respectively (P = 0.403) and that of CagA-positive H. pylori infection was 69.8% and 42.3%, respectively (P = 0.0002). The scores of the ECG S-T segment and T-wave abnormalities in the course of an exercise ECG in uninfected patients and in patients infected by CagA-negative and CagA-positive H. pylori strains were (mean ± sd): 1.59 ± 0.67, 1.92 ± 0.64, and 2.19 ± 0.70, respectively; (P = 0.011, 95% confidence limits of difference 0.15–1.07, CagA-positive infected vs uninfected patients). There was no intergroup difference in the levels of peripheral whiteblood cells, glucose, cholesterol, triglycerides, creatinine, and systolic and diastolic pressure. In conclusion, genetic heterogeneity of H. pylori could possibly explain some conflicting results concerning the association of H. pylori infection with IHD. Coronary vessels of IHD patients infected by CagA-positive H. pylori strains may be damaged more severely than those of uninfected patients.
Similar content being viewed by others
REFERENCES
Noll G: Pathogenesis of atherosclerosis: A possible relation to infection. Atherosclerosis 140(suppl 1):S3–S9, 1998
Becker AE, de Boer OJ, van Der Wal, AC: The role of inflammation and infection in coronary artery disease. Annu Rev Med 52:289–297, 2001
Epstein SE, Zhuo YF, Zhu J: Infection and atherosclerosis. Emerging mechanistic paradigms. Circulation 100:e20–e28, 1999
Danesh J, Collins RO, Peto R: Chronic infections and coronary heart disease: Is there a link? Lancet 350:430–436, 1997
Svrjaken J, Valtonen VV, Iivaninen M, Kaste M, Hutten JK: Preceding infections as an important risk factor for ischaemic brain infarction in young and middle aged patients. Br Med J 296:1156–1160, 1988
Feingold K, Grunfeld C: Role of cytokines in inducing hyperlipidaemia. Diabetes 41(suppl 2):97–101, 1992
Baumann H, Gauldie J: The acute phase response. Immunol Today 15:74–80, 1994
Graham D: Campylobacter pylori and peptic ulcer disease. Gastroenterology 96:615–625, 1989
Parsonnet J: Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am 22:89–104, 1993
Wotherspoon AC, Ortiz Hidalgo C, Falzon MR, Isaacson PG: Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175–1176, 1991
Graham DY, Osato MS, Olson CA, Zhang J, Figura N: Effect of H. pylori infection and CagA status on leukocyte counts and liver function tests: extra-gastric manifestation of H. pylori infection. Helicobacter 3:174–178, 1998
Perri F, Clemante R, Festa V, Checchia De Ambrosio C, Quitadamo M, Fusillo M, Grossi E, Andriuli A: Serum tumour necrosis factor-alfa is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol 31:290–294, 1999
Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm J, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437–439, 1994
Patel P, Mendall MA, Khulusi S, Northfield TC, Stracham DP: Helicobacter pylori infection in childhood: Risk factors and effect on growth. Br Med J 309:1119–1123, 1994
Tebbe B, Geilen CC, Schulzke J-D, Bojarski C, Radenhausen M, Orfanos CE: Helicobacter pylori infection and chronic urticaria. J Amer Acad Dermatol 34:685–686, 1996
Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC: Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71:437–439, 1994
Ossei-Gerning N, Moayyedi P, Smith S, Braunholtz D, Wilson JI, Axon AT, Grant PJ: Helicobacter pylori infection is related to atheroma in patients undergoing coronary angiography. Cardiovasc Res 37:120–124, 1997
Whincup P, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, Hawkey C, Atherton J: Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men. Circulation 101:1647–1652, 2000
Figura N: Pathogenetic mechanisms of Helicobacter pylori in gastroduodenal diseases. In Advances in Gastrointestinal Inflammation. A, Morelli, C, Surrenti, S, Fiorucci, L Santucci (eds). London; InterScience Publishing, 1999, pp 221–269
Webb PM, Crabtree JE, Forman D: Gastric cancer, cytotoxinassociated gene A-positive Helicobacter pylori, and serum pepsinogens: an international study. The Eurogast Study Group. Gastroenterology 116:269–276, 1999
Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, Covacci A: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that the clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating toxin. Infect Immun 63:94–98, 1995
Ellestad MH: Stress Testing—Principles and Practice, Edition 4. Turin, Centro Scientifico Editore, 1997
Figura N, Oderda G, Verdiani S: Evaluation of a commercial ELISA kit for the serological diagnosis of Helicobacter pylori infection. Microbiologica 17:319–325, 1994
Fong IW: Emerging relations between infectious diseases and coronary artery Can Med Assoc J 163:49–56, 2000
Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC.: Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78:273–277, 1997
Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE: Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32:385–391, 2001
Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, Fagetti L, Esposito G, Ruberti U, Allegra L: Detection of Chlamydia pneumonite but not H. pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 34:2766–2769, 1996
Cammarota G, Figura N, Cianci R, Pasceri V, Fedeli P, Lenzi C, Gasbarrini G: Is there antigenic mimicry between arteriosclerotic lesions and H. pylori antigens? Clin Biochem 33:419–421, 2000
Kowalski M, Konturek PC, Pieniazek P, Karczewska E, Kluczka A, Grove R, Kranig W, Nasseri R, Thale J, Hahn EG, Konturek SJ: Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 33:222–229, 2001
de Luis DA, Garcia Avello A, Lasuncion MA, Aller R, Martin de Argila C, Boixeda de Miquel D, de La Calle H: Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. Clin Nutr 18:227–231, 1999
Gauldie J, Richards C, Northemann W, Fey G, Baumann H: IFNB2/BSF2/IL-6 is the monocute-derived HSF that regulates receptor-specific acute phase gene regulation in hepatocytes. Ann NY Acad Sci 557:46–59, 1989
Pober S: Cytokine-mediated activation of vascular endothelium. Am J Pathol 133:426–433, 1988
Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A: Association of virulent Helicobacter pylori strains with ischaemic heart disease. Circulation 97:1675–1679, 1998
Gunn M, Stephens JC, Thompson JR, Rathbone BJ, Samani NJ: Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 84:267–271, 2000
Ponzetto A, La Rovere MT, Sanseverino P, Bazzoli F: Association of Helicobacter pylori infection with coronary heart disease Br Med J 311:711–714, 1996
Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G, Hombach V, März W, Pepys MB, Brenner H: Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease. Lack of a role of cytotoxin-associated protein A positive strains and absence of a systemic inflammatory response. Circulation 100:2326–2331, 1999
Maier F, Auricchio A, Nilius M, Dominguez-Munoz JE, Klein H: Lack of association between Helicobacter pylori infection and angiographically documented coronary heart disease. Gut 39(suppl 2):A92, 1996
Danesh J, Peto R: Risk factors for coronary heart disease and infection with Helicobacter pylori: Meta-analysis of 18 studies. Br Med J 316:1130–1132, 1998
Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J: Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41:442–511, 1997
Li CQ, Pignatelli B, Ohshima H: Coexpression of interleukin-8 and inducible nitric oxide synthase in gastric mucosa infected with cagA Helicobacter pylori. Dig Dis Sci 45:55–62, 2000
Ando T, Perez-Perez GI, Kusugami K, Ohsuga M, Bloch KC, Blaser MJ: Anti-CagA immunoglobulin G responses correlate with interleukin-8 induction in human gastric mucosal biopsy culture. Clin Diagn Lab Immunol 7:803–809, 2000
Figura N, Bugnoli M, Guglielmetti P, Musmanno RA, Russi M, Quaranta S: Antibodies to vacuolating toxin of Helicobacter pylori in dyspeptic patients. In: Helicobacter pylori and Gastroduodenal Pathology. JM Pajares (ed). Springer-Verlag, Berlin, 1993, pp, 181–186
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Figura, N., Palazzuoli, A., Faglia, S. et al. Infection by CagA-Positive Helicobacter pylori Strains in Patients with Ischemic Heart Disease: Prevalence and Association with Exercise-Induced Electrocardiographic Abnormalities. Dig Dis Sci 47, 831–836 (2002). https://doi.org/10.1023/A:1014708520885
Issue Date:
DOI: https://doi.org/10.1023/A:1014708520885